Side-by-side comparison of AI visibility scores, market position, and capabilities
NYSE: V global payments network at $35.93B FY2024 revenue with 4.48B cards and $15T+ annual volume; 52.2% credit card market share with 233.8B transactions competing with Mastercard and A2A payment rails.
Visa Inc. is a San Francisco-based global payments technology company — listed on NYSE (NYSE: V) — operating the world's largest electronic payment network connecting 4.48 billion active cards, 150+ million merchant locations, and 15,000+ financial institution partners across 200+ countries and territories, facilitating $15+ trillion in payment volume annually. Visa generated $35.93 billion in net revenues in fiscal year 2024 (+10% year-over-year) with $19.7 billion in net income (55% net margin) from payment volume fees, data processing fees, and international transaction fees — without issuing a single credit card or carrying any credit risk. Founded in 1958 as the BankAmericard program and reorganized as Visa Inc. through a 2008 IPO, Visa is the infrastructure provider that enables the global credit and debit card ecosystem to function: every Visa card issued by Citibank, Chase, HDFC, or 15,000 other banks worldwide runs on Visa's authorization, clearing, and settlement network.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.